Howard B. Cottam

University of California San Diego

Papers

1

Total Citations

58

H-Index

1

About

Howard B. Cottam is a pioneering researcher in the fields of extracellular vesicle (EV) biology and drug discovery, with a focus on understanding intercellular communication and its therapeutic implications. His major contributions include the development of a novel reporter cell line for the quantitative screening of EV release, a breakthrough that enables high-throughput identification of compounds modulating EV biogenesis. This work, published in 2021 and cited 58 times, has significant implications for immune system research, particularly in antigen presentation and cellular regulation. Cottam’s innovative approach bridges the gap between basic EV biology and translational drug discovery, offering tools to characterize small molecules that influence EV-mediated signaling. His research has been instrumental in advancing the study of EVs as key mediators in health and disease, with potential applications in cancer, inflammation, and neurodegenerative disorders. Through his work, Cottam has established himself as a leader in EV research, providing critical resources for the scientific community to explore the therapeutic modulation of extracellular vesicle release.

Research Focus

Key Achievements

1
H-Index
1
Papers
58
Total Citations
58
Avg Citations/Paper
🏆 Most Cited Paper
Generation and Application of a Reporter Cell Line for the Quantitative Screen of Extracellular Vesicle Release
58 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: University of California San Diego

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago